Straits Times Index
3,291.38 +9.33 (+0.28%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,175.70 +28.67 (+0.35%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,312.01 -27.06 (-2.02%)
BioCryst Pharmaceuticals, Inc. (BCRX)
After hours:
| Previous close | 4.1600 |
| Open | 4.2000 |
| Bid | 4.2500 x 1400 |
| Ask | 4.2800 x 700 |
| Day's range | 4.1450 - 4.3500 |
| 52-week range | 4.0300 - 9.0700 |
| Volume | |
| Avg. volume | 3,196,262 |
| Market cap | 881.033M |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1800 |
| Earnings date | 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.82 |
ZacksBioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to...
GlobeNewswireBioCryst to Report First Quarter 2024 Financial Results on May 6
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live
